Latest radiopharmaceuticals Stories

TORONTO, Nov. 17, 2010 /PRNewswire/ -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, has released its latest imaging research data on diagnostic imaging, X-ray, radiopharmaceuticals, and contrast agent markets. MRG's X-ray reports cover cardiovascular X-ray systems such as cardiology and peripheral vascular X-ray systems, general radiography systems, surgical X-ray systems, fluoroscopy systems, and analog and digital mobile radiography...

Hoag Memorial Hospital Presbyterian recently announced encouraging clinical study results for patient-specific vaccine therapy to treat metastatic melanoma. The study is ongoing, but the report concludes that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases, as demonstrated in one particular patient who participated in the trial.The study report, entitled: "Durable Complete Response of Refractory, Progressing,...

Immune cell function in an individual can be monitored noninvasively in the clinic using a technique known as a PET scan. A team of researchers, led by Owen Witte, at the University of California, Los Angeles, has now determined that in mice two different PET probes used in the clinic to monitor immune cell function detect distinct immune cell populations. These data have implications for the interpretation of clinical PET scans performed with these two probes and suggest these probes could...

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Radiopharmaceuticals - A US and European Market Analysis http://www.reportlinker.com/p0164273/Radiopharmaceuticals---A-US-and-European-Market-Analysis.html The market for radiopharmaceuticals continues to gain momentum with heightened interest in therapeutic efficiency, acceptance and utilization of nuclear medicine equipment, as well as development of newer...

NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Imaging Agents - A Worldwide Market Review http://www.reportlinker.com/p0164325/Imaging-Agents---A-Worldwide-Market-Review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Development of contrast agents revolutionized the visualization of organs within the human body. With their inherent ability to bring discrete organs and tissues to...

NEW YORK, Sept. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. US and European Radiopharmaceuticals Market http://www.reportlinker.com/p0109914/US-and-European-Radiopharmaceuticals-Market.html This report analyzes the US and the European markets for Radiopharmaceuticals in Millions of US$. The major product segments analyzed are Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. Annual forecasts are...

NEW YORK, Sept. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Biologic Imaging Reagents: Technologies and Global Markets http://www.reportlinker.com/p099465/Biologic-Imaging-Reagents-Technologies-and-Global-Markets.html INTRODUCTION STUDY GOALS AND OBJECTIVES BCC's goal for this study is to determine the global market and future demand growth for biologic imaging reagents over a five-year period from 2008 to 2013. Our...

Bracco's Cardiogen-82(R) Enables Cardiologists to Better Detect Cardiovascular Disease OTTAWA, June 10 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, today announced that it has commenced the manufacture of CardioGen-82(R) (Rubidium-82 generators), for Bracco Diagnostics, Inc. (part of Bracco Group), one of the world's leading companies in the imaging agent business. MDS Nordion has designed and built a dedicated...

New Omaha facility to help advance the early diagnosis and treatment of disease DUBLIN, Ohio, March 16 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced that it has opened a new facility in Omaha, Neb. that manufactures radiopharmaceuticals, giving local physicians new tools that aid in the early diagnosis and treatment of disease. The new manufacturing facility, known as a...

Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, and PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, Inc. and a leader in radiopharmaceutical distribution, jointly announced they have entered into a co-marketing agreement to offer a combined portfolio of high energy and low energy radioisotopes to the nuclear medicine community in the United States. Through the agreement, Covidien Imaging Solutions and PETNET will create a...